DCF — OVERLAND PARK REGIONAL MED CTR
Enterprise Value: $288.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$288.2M
Enterprise Value
$73.4M
PV of Cash Flows
$214.8M
PV of Terminal Value
$346.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $465.7M | $39.6M | 9.0% | $12.9M | $11.7M |
| Year 2 | $479.7M | $45.6M | 10.0% | $16.9M | $13.9M |
| Year 3 | $494.1M | $51.9M | 11.0% | $21.1M | $15.8M |
| Year 4 | $508.9M | $56.0M | 11.0% | $23.6M | $16.1M |
| Year 5 | $524.2M | $59.0M | 11.0% | $25.3M | $15.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $288.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$452.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000106152654
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5